Ryan Reynolds and Willie Geist Talk Dads With Parkinson’s Disease [MSNBC.com]
ACADIA Pharmaceuticals Inc. (ACAD)
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
Company Research
Source: MSNBC.com
In part two of this Sunday Sitdown Live, Ryan Reynolds and Willie Geist talk about the bond they share over their dads with Parkinson’s Disease and share how Michael J. Fox has become a North Star for the community. Then, Ryan takes questions from the audience.(Sponsored by More to Parkinson’s and brought to you by Acadia Pharmaceuticals Inc. Venue sponsored by City Winery)April 19, 2026
Show less
Read more
Impact Snapshot
Event Time:
ACAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACAD alerts
High impacting ACADIA Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ACAD
News
- Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual MeetingBusiness Wire
- Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026Business Wire
- Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett SyndromeBusiness Wire
- A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Shares Trade Near Recent Levels [Yahoo! Finance]Yahoo! Finance
- ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.MarketBeat
ACAD
Earnings
- 2/25/26 - Beat
ACAD
Sec Filings
- 4/7/26 - Form 4
- 4/7/26 - Form 4
- 3/26/26 - Form 4
- ACAD's page on the SEC website